MPXV B6R (AA 20-279) anticorps
Aperçu rapide pour MPXV B6R (AA 20-279) anticorps (ABIN7572172)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-279
-
Fonction
- Anti-Monkeypox virus/MPXV B6R/SL-159 Polyclonal Antibody
-
Purification
- Antigen affinity purification.
-
Immunogène
- E. coli - derived recombinant Monkeypox virus/MPXV B6R/SL-159 (Thr20-His279).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
-
: "Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus." dans: Cell reports, Vol. 43, Issue 6, pp. 114269, (2024) (PubMed).
: "Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 32, Issue 6, pp. 1779-1789, (2024) (PubMed).
-
: "Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus." dans: Cell reports, Vol. 43, Issue 6, pp. 114269, (2024) (PubMed).
-
- MPXV B6R
-
Sujet
- B6R/SL-159, Monkeypox virus (MPXV)
Antigène
-